Alan W. Dunton
At a glance: Alan W. Dunton is Director at CorMedix (CRMD). Their latest SEC Form 4, filed Jan 2, 2026, reported a sale of $260K. On file: 0 purchase lines ($0) and 1 sale line ($260K).
Disclosed holdings: about $203K of CRMD stock: 40,250 shares reported on their latest Form 4 (filed Jan 2, 2026), valued at the Nov 19, 2026 close of $5.04. This counts only CRMD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at CorMedix Inc. (CRMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Alan W. Dunton's InsiderPrint
5 trades from SEC Form 4 filings, 2020 to 2025, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $20K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (4)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Denise L. DevineDirector · SLQT · 98% match
- Stephen T. WillsCFO, COO · PTN · 97% match
- James OfferdahlDirector · LAW · 95% matchTheir buys since 2023: 3 of 3 beat the S&P 500
- Joseph TodiscoCEO · CRMD · 92% matchTheir buys since 2020: 5 of 7 beat the S&P 500
- Alexander A. FitzpatrickGeneral Counsel · SPRY · 89% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2020
From the SEC's insider data sets: each open-market buy by Alan W. Dunton, matched to how the stock did over the next 90 days against the S&P 500.
2 of 3 buys beat the S&P 500 (67%), median +9.2% vs. the index. Small sample: treat with care. All insider buys: 46%.
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 2SEC | CRMDCorMedix Inc. | Sell Plan | 20,00040,250 held (−33%) | $13.00 | $260K | -61.3% |
- Sell
Director Alan W Dunton sold $260K of CRMD at $13.00 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.
Follow Alan W. Dunton
Get one email when Alan W. Dunton files a new purchase or sale. Free.
At most one email a day about Alan W. Dunton, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.